Connor, Clark & Lunn Investment Management (CC&L)’s Cipher Pharmaceuticals Inc. CPHR Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CPHR Stock Details CPHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-53,900	Closed	-$206K	–	1070
2016 Q3	$206K	Buy	53,900 +1,900	+4%	+$8.66K	﹤0.01%	732
2016 Q2	$270K	Buy	+52,000	New	+$296K	﹤0.01%	695

Other funds holding CPHR

GPGA

Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return

NEI

Northwest & Ethical Investments Toronto, Ontario, Canada $4.32B AUM 23.26% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s CPHR Position: Q4 2016 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Cipher Pharmaceuticals Inc. (CPHR) in Q4 2016, closing a stake of 53,900 shares — an estimated $206K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CPHR in Q2 2016 and held it in 2 quarters. The position peaked at $270K in Q2 2016. 3 funds tracked by Wall St. Rank hold CPHR as of Q4 2016.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Cipher Pharmaceuticals Inc. position as of Q4 2016 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 53,900 Cipher Pharmaceuticals Inc. shares in Q4 2016, an estimated $206K.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Cipher Pharmaceuticals Inc. in Q2 2016 and held it in 2 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Cipher Pharmaceuticals Inc. position peaked at $270K in Q2 2016.
3 funds tracked by Wall St. Rank held Cipher Pharmaceuticals Inc. as of Q4 2016.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2016, filed 13 Feb 2017.